Multivariate analysis of race and adverse pathologic findings after radical prostatectomy.

[1]  S. Freedland,et al.  Race is not an independent predictor of biochemical recurrence after radical prostatectomy in an equal access medical center. , 2000, Urology.

[2]  S. Freedland,et al.  Clinical characteristics in black and white men with prostate cancer in an equal access medical center. , 2000, Urology.

[3]  M. Banerjee,et al.  Prostate cancer biochemical recurrence stage for stage is more frequent among African-American than white men with locally advanced but not organ-confined disease. , 2000, Urology.

[4]  J. Eastham,et al.  Race is not an independent predictor of positive surgical margins after radical prostatectomy. , 1999, Urology.

[5]  R. Vollmer,et al.  Predicting tumor failure in prostate carcinoma after definitive radiation therapy: limitations of models based on prostate-specific antigen, clinical stage, and Gleason score. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[6]  Wei Zhang,et al.  Racial differences in tumor volume and prostate specific antigen among radical prostatectomy patients. , 1999, The Journal of urology.

[7]  J. W. Box,et al.  Surgical control of clinically localized prostate carcinoma is equivalent in African‐American and White males , 1998, Cancer.

[8]  I. Powell.  Prostate cancer in the African American: is this a different disease? , 1998, Seminars in urologic oncology.

[9]  D. Johnston,et al.  Prostate specific antigen and pathological features of prostate cancer in black and white patients: a comparative study based on radical prostatectomy specimens. , 1998, The Journal of urology.

[10]  D. Grignon,et al.  The predictive value of race as a clinical prognostic factor among patients with clinically localized prostate cancer: a multivariate analysis of positive surgical margins. , 1997, Urology.

[11]  J. Moul,et al.  Black race is an adverse prognostic factor for prostate cancer recurrence following radical prostatectomy in an equal access health care setting. , 1996, The Journal of urology.

[12]  F. Mostofi,et al.  Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men. , 1995, JAMA.

[13]  T. Wheeler,et al.  Prostate specific antigen and gleason grade: an immunohistochemical study of prostate cancer. , 1994, The Journal of urology.

[14]  M. Riggs,et al.  Stage at presentation and survival of white and black patients with prostate carcinoma , 1993, Cancer.

[15]  Max H. Myers,et al.  Manual for Staging of Cancer , 1992 .

[16]  J. Epstein,et al.  Evaluation of Radical Prostatectomy Specimens: A Comparative Analysis of Sampling Methods , 1992, The American journal of surgical pathology.

[17]  Gleason Df.  Classification of prostatic carcinomas. , 1966 .

[18]  Taylor Murray,et al.  Cancer statistics, 2000 , 2000, CA: a cancer journal for clinicians.

[19]  M. Kattan,et al.  Disease recurrence in black and white men undergoing radical prostatectomy for clinical stage T1-T2 prostate cancer. , 2000, The Journal of urology.

[20]  M. Banerjee,et al.  Population-based study of pelvic lymph node positivity in clinically localized prostate cancer: a study comparing African Americans and whites. , 1999, Urology.

[21]  K. Pienta,et al.  Effect of age and race on the survival of men with prostate cancer in the Metropolitan Detroit tricounty area, 1973 to 1987. , 1995, Urology.